- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone-resistant Prostate Cancer in United States
Total 7273 results
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingProstate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
BayerTerminatedProstatic Cancer, Castration-ResistantUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)Active, not recruitingLocalized Prostate Cancer | Active Surveillance for Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNeuroendocrine Prostate Cancer | Small Cell Prostate Cancer | Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine MarkersUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
POM Wonderful LLCCompletedRecurrent Prostate CancerUnited States
-
Five Eleven Pharma, Inc.Indiana UniversityActive, not recruitingProstate Cancer | Prostate Cancer RecurrentUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedRecurrent Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCCompletedStage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
Julie Graff, MDJohns Hopkins University; Merck Sharp & Dohme LLC; Oregon Health and Science... and other collaboratorsRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States
-
Indiana UniversityIndiana University School of MedicineCompletedProstate Cancer RecurrentUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Global Isotopes, LLC d/b/a Zevacor MolecularCompletedMetastatic Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseUnknown
-
University of ChicagoRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer MetastaticUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Hyperplasia | Prostate Cancer | Cancer Of Prostate | Prostatic Cancer | Prostatic NeoplamsUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
Momotaro-Gene Inc.The Pacific Link Consulting CoCompletedLocalized Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
Dana MathewsNo longer availableProstate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
Calibr, a division of Scripps ResearchTerminatedMetastatic Castration-Resistant Prostate AdenocarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | PSA Failure | PSA Progression | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Carcinoma Metastatic in the BoneUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
NYU Langone HealthCompleted
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.TerminatedMetastatic Disease | Castration-Resistant Prostatic CancerUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
OHSU Knight Cancer InstituteThe Wayne D. Kuni and Joan E. Kuni FoundationCompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Mamta ParikhNational Cancer Institute (NCI); PandomedxCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States
-
Cedars-Sinai Medical CenterRecruitingProstate Cancer Stage II | Prostate Cancer Stage I | Bladder Cancer Stage II | Kidney Cancer Stage IUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
National Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Lymph NodesUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
Albert DeNittisUnknown
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of MiamiNational Cancer Institute (NCI)CompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasms, ProstateUnited States
-
National Cancer Institute (NCI)CompletedProstate Cancer | Prostate NeoplasmUnited States
-
University of MiamiWithdrawnProstate Cancer | Prostate AdenocarcinomaUnited States